首页 › 基金 › Gem Investment Advisors, LLC › LFCR

Gem Investment Advisors, LLC 对 LFCR 的持仓历史

LIFECORE BIOMEDICAL INC · 医疗保健

Gem Investment Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 LFCR(LIFECORE BIOMEDICAL INC)13,000 股,市值约 US$86K,约占其申报组合的 0.06%,在其申报持仓中市值排名第 29 位。 Gem Investment Advisors, LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)13.00K 股
申报持仓市值$85.54K
组合权重0.06%
首次申报Q3 2026
最近变动新进
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Gem Investment Advisors, LLC 对 LFCR 的持仓演变

Gem Investment Advisors, LLC 于 Q3 2026 首次披露 LFCR 持仓:13,000 股(约 US$86K)。

逐季持仓明细

季度股数金额变化
Q3 2026 13.00K $85.54K 新进

关于 LFCR 与 13F 数据

LFCR(LIFECORE BIOMEDICAL INC)属于医疗保健行业。我们追踪的基金中还有 21 只申报持有 LFCR,申报仓位最大的包括:WYNNEFIELD CAPITAL INC (US$24.7M), Legion Partners Asset Management, LLC (US$23.4M), Greenhaven Road Investment Management, L.P. (US$18.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 LFCR 的基金

查看 LFCR 的全部基金持有人 →

常见问题

How long has Gem Investment Advisors, LLC held LFCR?

Gem Investment Advisors, LLC has disclosed LFCR holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Gem Investment Advisors, LLC's current position in LFCR?

As of Q3 2026, Gem Investment Advisors, LLC holds 13.00K shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $85.54K, representing 0.06% of its reported portfolio and ranking #29.

Has Gem Investment Advisors, LLC been buying or selling LFCR?

In the latest 13F filing (Q3 2026), Gem Investment Advisors, LLC newly opened its position in LFCR.

Which other funds hold LFCR?

Other major institutional holders of LFCR include WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.